Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Overview of attention for article published in Nature Medicine, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 50 news outlets
blogs: 7 blogs
twitter: 117 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 3 Redditors

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 79 news stories from 50 outlets.

Could Next-Generation Medicines Help Solve the Opioid Crisis? todayheadline

Today Headline, 30 Dec 2025

On June 11, 2018, seeking relief from chronic pancreatitis pain, Ashley Romero took what she believed to be half a pill of…

Okie Tokie Talk: Adolescent Cannabis Use in Oklahoma, the Sooner State

UBM Medica, 02 Dec 2025

Adolescent cannabis use surges in Oklahoma, raising public health concerns amid rising THC potency and permissive regulations.

Aelis Farma Announces the Final Analysis of the Landmark Phase 2B Clinical Trial in Cannabis Use Disorder (CUD) with the CB1-SSi AEF0117

Business Wire, 26 Mar 2025

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Two videoconferences will be held tomorrow, March 27, 2025 in French at 05:30…

News story from Finanz Nachrichten on Wednesday 26 March 2025

Finanz Nachrichten, 26 Mar 2025

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 75 additional news stories.